Delivery Order SPE2DB22D1106-SPE2DB25FEXQ8
- Not listed
- The Defense Logistics Agency awarded a $6,978.90 delivery order to AmerisourceBergen Drug Corp for Latuda 40 mg tablets (30-count units) on September 18, 2025, with a completion date of September 19, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Latuda 60 mg tablets in a quantity of 30 units. This is a firm fixed price delivery order with a ceiling value of $5,418.64 and an ultimate completion date of September 11, 2025. The contract was awarded without a set-aside designation through competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on September 2, 2025, for the supply of Latuda 60 mg tablets (30-count packaging) with a ceiling value of $6,445.00 under a firm fixed price contract. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which carries a total value of $999,999,999.00 and extends through December 2026. The order is to be fulfilled...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Latuda 20 mg tablets in a quantity of 30 units. This competitive award, valued at $15,367.79, carries a firm fixed price structure with an ultimate completion date of August 29, 2025. The delivery order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,188.91, is for the supply of 4,567,983,932 units of the prescription medication Latuda 40 mg tablets. The contract has an ultimate completion date of April 22, 2025. AmerisourceBergen Drug Corp, a for-profit organization headquartered in Conshohocken, Pennsylvania, is delivering these pharmaceutical products to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Latuda 120 mg tablets (30-count) with a ceiling value of $5,207.81. The contract was competitively awarded without set-aside designation and is classified as a firm fixed price delivery order, with an ultimate completion date of August 26, 2025. Performance will be executed from the vendor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Latuda 120 mg tablets (30-count) with a ceiling value of $41,891.62. This firm fixed-price contract, awarded on September 8, 2025, with a completion date of September 9, 2025, represents a non-competitive set-aside delivery order issued under DLA's broader pharmaceutical procurement framework. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) awarded a $4,994.14 firm-fixed-price delivery order (SPE2DB20D3111|SPE2DB23FB0EB) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4562215936 Latuda 40 mg tablets. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., which was awarded by the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
- This is a $8,663.90 delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of LATUDA 40 MG TABLET 30S, a pharmaceutical product. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which covers a broad range of pharmaceutical and medical supply products to support military...
- The Defense Logistics Agency awarded a delivery order valued at $10,999.03 to AmerisourceBergen Drug Corp for the supply of Latuda 120 mg tablets (30-count packages) on September 2, 2025, with a completion date of September 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEXQ8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Latuda 40 mg tablets (30-count units) valued at $7,754.48 under a firm fixed price contract structure. This non-set-aside award was competitively procured and is scheduled for completion by July 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and will fulfill this order from its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026. The parent IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs and other federal healthcare systems worldwide. Latuda, an antipsychotic medication, represents one of the specialized pharmaceutical products AmerisourceBergen routinely delivers through its federal contracts serving the Defense Health Agency and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.8k | 7/14/25 |